<i>CDKN2AIPNL</i> exhibits a paradoxical role in cancer, acting as a tumor suppressor in myeloid malignancies but promoting solid tumor progression, yet its systematic pan-cancer characteristics remain unelucidated. Here, XTBD1 is linked to neoplasm.